Cognition Therapeutics Inc.

Biotechnology • Healthcare • Purchase, NY, United States • CGTX (NCM)

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Will Cognition Therapeutics (NASDAQ:CGTX) Spend Its Cash Wisely? - Yahoo Finance

Yahoo Finance • Dec 5

Cognition Therapeutics Launches New $75M ATM Offering - TipRanks

TipRanks • Dec 18

Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX) - Seeking Alpha

Seeking Alpha • Nov 21

Cognition Therapeutics (NASDAQ: CGTX) maps Phase 3 AD trial after 95% decline slowdown - Stock Titan

Stock Titan • Dec 1

DAVENPORT & Co LLC Makes New Investment in Cognition Therapeutics, Inc. $CGTX - MarketBeat

MarketBeat • Dec 27

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has COGNITION THERAPEUTICS INC had layoffs?

No layoff events have been recorded for COGNITION THERAPEUTICS INC in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does COGNITION THERAPEUTICS INC have?

COGNITION THERAPEUTICS INC has approximately 25 employees.

What industry is COGNITION THERAPEUTICS INC in?

COGNITION THERAPEUTICS INC operates in the Biotechnology industry, within the Healthcare sector.

Is COGNITION THERAPEUTICS INC a publicly traded company?

Yes, COGNITION THERAPEUTICS INC is publicly traded under the ticker symbol CGTX on the NCM. The company has a market capitalization of approximately $0.13 billion.

Where is COGNITION THERAPEUTICS INC headquartered?

COGNITION THERAPEUTICS INC is headquartered in Purchase, NY, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.